CYP1A1 and Hypertension: In contrast, when induction is aimed at producing a non-malignant stable hypertension, chronic amiloride treatment causes a transiently negative sodium balance and abolishes hypertension in cyp1a1-Ren2 TGR [3], even though ENaC mRNA levels do not change.